Edderkaoui B, Kesavan C, Baylink DJ, Wergedal JE, Srivastava AK, Mohan S. ENU mutation mapped to a distal region of chromosome 11 is a major determinant of bone size.
initial mutation renders the screening system highly sensitive to small changes due to synergism. This approach has been successfully demonstrated in drosophila to uncover genes in the Notch signaling pathway (8) . Using this modified screen, we recently described a bone size mutant mouse strain in a growth hormone (GH)-deficient mice strain (Ghrhr lit/ϩ ). The mutant mice, named 14104, exhibited a smaller periosteal circumference and bone cross-sectional area at the midshaft tibia, femur, and humerus (9) . We backcrossed the 14104 mice with Ghrhr lit/ϩ and Ghrhr ϩ/ϩ mice and confirmed heritability of the bone size mutation in both Ghrhr lit/ϩ and Ghrhr ϩ/ϩ genetic backgrounds.
In this study, we further characterized the skeletal phenotype of mice by microcomputed tomography (CT) and static and dynamic histomorphometric analyses. We determined the chromosomal location of the 14104 mutation by fine-mapping the mutant locus to a smaller region and explored potential candidate genes in the region by sequence analyses and other genomic approaches. Furthermore, we evaluated whether the 14104 locus is involved in the mechanical loading pathway since mechanical strain is an important contributor of periosteal expansion. Our studies revealed that the 14014 gene is a novel gene that regulates bone size in response to mechanical strain.
MATERIALS AND METHODS
Mice and bone phenotype. All mice were housed under conventional conditions and handled according to the guidelines established by the Institutional Animal Care and Use Committee (IACUC) of Loma Linda VA Healthcare Systems (LLVAHCS). All animal procedures were approved by the LLVAHCS IACUC. The GHRHR mutant "little" mice (Ghrhr lit/lit ) were obtained from The Jackson Laboratory (Bar Harbor, ME) and bred in our facility to produce Ghrhr lit/ϩ heterozygous mice. The generation of mutant mice, ID 14104, were backcrossed over five generations, and preliminary phenotype measurements have been reported previously (9) . Phenotype distribution was used to differentiate the mutants from their unaffected littermates. The offspring were screened at different ages (1-16 wk) to identify affected mice based on cross-sectional area measured by peripheral quantitative computed tomography (pQCT) (Norland Stratec XCT960M; Stratec Medizintechnik, Madison, WI) and CT (VivaCT 40; SCANCO Medical, Bruttisellen, Switzerland). Progeny were genotyped for Ghrhr lit/ϩ and Ghrhr ϩ/ϩ with a single nucleotide polymorphism (SNP) assay as described previously (9) . Cortical and trabecular bone microarchitectures of the femurs isolated from 12 wk old mutant and wild-type (WT) mice were assessed by CT, femurs were scanned by X-ray, and the scanned image was then contoured to either include or exclude cortical bone. For trabecular bone parameters, slices chosen for analysis were based on the location of the growth plate and adjusted based on bone length so the regions of interest chosen for trabecular and cortical bone parameters were anatomically the same for the mutant and the WT control mice. After image postprocessing, the bone volume (BV), tissue volume (TV), and the ratio BV/TV, trabecular thickness (Tb. Th), trabecular separation (Tb. Sp), and trabecular number were calculated in the morphologic analysis.
Histomorphometric measurements. The 14104 mutant and WT control mice were injected with 20 mg/kg of calcein at a 2 wk interval when mice were 14 wk old. Femurs were dissected, fixed, and processed for histomorphometric measurements as described previously (14) .
In vitro proliferation assay for periosteal osteoblast cells. Methods for isolation of periosteal osteoblast cells and measurement of proliferation have been described earlier (15, 16) . To obtain quantitative differences, we used periosteal osteoblasts-derived from four mutant and four control mice for each experiment.
Measurement of bone breaking strength. Bone strength parameters were determined from the right tibia by the three-point bending technique with the DynaMight testing system (model 8840; Instron, Norwood, MA) as previously described (4, 24) .
Axial loading of the tibia. At 10 wk of age, both mutant and WT mice were subjected to axial loading, 40 cycles with 10 s of rest between each cycle, once per day, 3 days per week for 2 wk as previously described (6, 19) . For an accurate comparison of bone response to loading between the mutant and the WT mice, we normalized the small bone size of the mutant mice to their WT control bones by administering loads that produce equivalent amount of mechanical strain in the two sets of mice. The strain produced by axial loading at the cortical site (middiaphysis) and trabecular site (metaphysis) was measured by a strain gauge technique, as described elsewhere (6), in isolated tibias of WT and mutant mice. The applied loads produced 3,056 and 2,937 ⑀ of strain in the diaphyseal region of WT and mutant mice, respectively. The same loads produced strain equivalents to 621 and 641 ⑀ in the metaphyseal region of WT and mutant mice. Skeletal changes were measured by CT measurements with a 75 kV X-ray at a resolution of 10.5 m as described previously (6, 18) .
Mapping the 14104 mutation. Heterozygous mutant 14104 mice generated after five backcrosses with the founder mouse were crossed into DBA/2J (DBA) to generate F1 mice. The mutant 3 wk old DBA.B6 F1 offspring from this mating were screened and crossed with unaffected DBA.B6 F1 mice. The 3 wk old F2 mice were screened for periosteal circumference and cross-sectional area in vivo with pQCT (data not shown). Six-week-old F2 animals were killed, and femurs were collected for ex vivo pQCT analysis (16, 16a) . Nine slices covering the entire length of each F2 femur were scanned. The middle three slices, representing diaphyseal bone, were used for linkage analysis. DNA samples from F2 mice were used to scan the genome by selective genotyping and a phenotypic pooling method. Briefly, DNA was isolated with a Qiagen DNA isolation kit, and the DNA concentration was determined by spectrophotometry. We then pooled an equal amount of DNA from 35 F2 mice representing the lowest 15% fraction of the F2 population (representing the mutant phenotype). A control pool was established with equal amounts of DNA from the WT B6.DBA F1, B6, and DBA mice. The final concentration of DNA in the pools was adjusted to 10 ng/l. The allele densities were measured with an ABI model 3100 DNA Analyzer (Applied Biosystems) as described previously (16) . Initially, we used 44 microsatellite markers that differ in size between DBA and B6, spaced evenly throughout the genome, and used pooled DNA samples from mutant F2, WT F2, DBA, and B6 mice. The order of genetic markers was obtained for each chromosome from a publicly available Mouse Genome Informatics database (MGI 3.22, http:// www.informatics.jax.org/). Our genome-wide analysis revealed linkage of the mutant phenotype to chromosome 11. Additional mice and microsatellite markers were used to reduce the linked interval. The WT littermates were used to confirm that there was no linkage between bone size and this region of chromosome 11 in these animals. Fine-mapping of the 14104 mutation in chromosome 11 was carried out with 18 mit polymorphic markers in the identified region and DNA from individual B6.DBA F2 progeny.
Sequence analysis. The list of genes in the mutant locus was established from the Mouse Genome Informatics database (data not shown). To identify the mutation caused by ENU treatment in the selected candidate genes, we used direct DNA sequence analysis of PCR products. Gene-specific primers were used to amplify overlapping regions from the start codon to the stop codon of each gene using the B6 sequence from NCBI. The resulting PCR products were directly sequenced utilizing an ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA).
Statistical analyses. Phenotype data of the F1 and F2 populations were analyzed with Graph Pad Prism (Windows version 4.02; GraphPad Software, San Diego, CA). All data are presented as means Ϯ SD unless otherwise stated. The Shapiro-Wilk test was used to test the normality of phenotypic data from F2 mice. A t-test or one-way ANOVA analysis with Newman-Keuls test was used to compare data pairs to determine statistically significant differences between mutants and WT B6 mice.
Genotype data were analyzed with the Pseudomarker MAINSCAN algorithm written for MATLAB (Mathworks, Natick, MA) programming environment as described previously (16, 23) . The genome wide cut-off value for significant logarithm of the odds (LOD) scores was determined by the 1,000 permutation test (17) . The 95% confidence intervals (CI) were derived from posterior probability density plots for an individual chromosome as described previously (13) . Because we used body weight-adjusted periosteal circumference as the phenotype, we combined the male and female data for interval mapping. We genotyped all F2 mice to determine if they carried Ghrhr lit/ϩ of Ghrhr ϩ/ϩ alleles.
RESULTS
The 14104 mutation was inherited as an autosomal dominant trait, and the mutant phenotype was expressed in both Ghrhr lit/ϩ and Ghrhr ϩ/ϩ genotypes. The bone size parameters analyzed by CT at the femur middiaphyseal region confirmed the difference in bone size previously reported from pQCT measurements (9) and showed a 43% reduction in total area (TA, P Ͻ 0.01) and a 34% reduction in cortical bone area (BA, P Ͻ 0.01) in femurs derived from 12 wk old female mutant 14104 mice compared with age-and sex-matched WT mice (Fig. 1, A-C) . However, BA/TA was significantly greater (18%, P Ͻ 0.01) in the mutant compared with WT mice (Fig.  1D) . In contrast to the increased cortical BA/TA at the middiaphysis, trabecular BV/TV at the femur metaphyseal region was not significantly different between the mutant and control mice ( Table 1 , P ϭ 0.9), but TV and BV were significantly reduced at the femur metaphysis of the mutant compared with control mice (Table 1 , P Ͻ 0.05).
The histomorphometric measurements at the femur middiaphysis revealed a 58% reduction in bone formation rate (BFR) at periosteal surfaces in the 14104 mice (P Ͻ 0.05, n ϭ 8) compared with control (n ϭ 6) mice ( Fig. 2A) . However, at the endosteum, BFR was not significantly different between the mutant and control mice. The TRAP-stained surface at the endosteal surface was reduced by 29% and increased by 8% at the periosteal surface in the mutant mice versus control mice, but the differences were not significant between the two lines of mice (P Ͼ 0.05) (Fig. 2B) . Importantly, dynamic histomorphometric studies reveal that the reduced bone formation rate at the periosteum was primarily due to decreased labeled surface (P ϭ 0.02, Fig. 2A ), a measure of osteoblast number and not due to a decrease in the mineral apposition rate (P ϭ 0.4, Fig. 2A ), a measure of osteoblast activity.
We compared proliferation rates of periosteal cells derived from the mutant 14104 and the WT mice by two different methods: alamar blue and incorporation of 3 H-thymidine into DNA. The basal proliferation rate was 40 -50% lower in cells derived from the 14104 mice compared with normal littermates (Fig. 3, A and B) . These observations were consistent with the histomorphometric data that revealed decreased osteoblast cell numbers.
The mechanical strength is directly proportional to the crosssectional area of bone. As expected, the three-point bending test revealed that maximum failure loads were 30% lower in 14104 mice than in WT control mice (Fig. 4) . The maximum failure load for mutant was slightly lower than what could be predicted from 40% lower cross-sectional moment of inertia values in 14104 mice (data not shown). One potential explanation for this that the increased cortical thickness in the mutant mice could represent a compensatory mechanism to account partly for the mechanical strength deficit caused by the drastic reduction in bone size.
Due to difference in bone size, we measured mechanical strain at the diaphysis and metaphysis with a strain gauge in both WT and mutant female mice and then applied loads that produced a similar amount of mechanical strain in both mice lines. In response to 2 wk of axial loading, the WT mice showed a 6% increase in tissue area and a 5% increase in BA/TA at the femur middiaphysis of WT mice (P Ͻ 0.01, n ϭ 6, Fig. 5A ). Mechanical loading-induced a cortical bone response that was drastically reduced in the 14014 mutant mice compared with control mice (Fig. 5A) . In addition to the cortical parameters, we also measured trabecular parameters in the secondary spongiosa after 2 wk of axial loading in the mutant and WT mice. In response to loading, the WT mice demonstrated a 25-40% increase in trabecular BV/TV, Tb. Th (Fig. 5B) , and Tb. density (data not shown) and a 9% reduction in Tb. Sp (Fig. 5B) . By contrast, none of the trabecular bone parameters were significantly altered by axial loading in the 14104 mutant mice (Fig. 5B) .
We bred 14104 heterozygous (mutant B6) mice with the DBA strain to generate 28 F1 mice, which were intercrossed to produce 182 F2 mice. The phenotype distributions of F1 and F2 mice are shown in Fig. 6, A and B . Consistent with the autosomal dominant trait, ϳ50% of the F1 mice had a 20% reduction in periosteal circumference, (P Ͻ 0.001 vs. normal littermate and WT F1 mice). The phenotype distribution of F2 mice showed two distinct populations, mutant and WT (Fig.  6B) . Interval mapping using the Pseudomarker MAINSCAN algorithm to identify the linkage between polymorphic markers in chromosome 11, and femur periosteal circumference within the F2 female mice showed a peak, with an LOD score of 15 at marker D11mit338 (Fig. 7) that was significantly associated with femur middiaphysis periosteal circumference. Since the phenotype is influenced by the presence of the "lit" allele, the lit genotype was used as a covariant to determine linkage. Posterior probability density, which is a likelihood statistic that gives rise to the 95% CI, disclosed a support interval at 109 -119 Mb (http://www.informatics.jax.org/). The physical distance was based on markers D11mit181 (71.88 cM and 109.3 Mb) and D11mit104 (83.36 cM and 119.3 Mb), which showed a significant contribution to the bone size phenotype (Fig. 7) . Figure 8 shows the mean periosteal circumference values for the three genotypes of F2 mice representing the chromosomal marker D11mit338. Alleles for the peak markers on the chromosome 11 interval that were inherited from the B6 parental strain contributed to ϳ20% lower (P Ͻ 0.001) periosteal circumference than alleles inherited from DBA/2J mice, a finding that is consistent with the observed 20% difference in periosteal circumference between WT and mutant mice. Based on the one-way ANOVA, the phenotypic effect of the B6 mutant allele best fits an additive model.
The physical map of 95% CI of the 14104 locus was mapped to a region extending from 109.3 to 119.3 Mb. Using the Mouse Genome Informatics website (MGI 3.51, http:// www.informatics.jax.org/), we identified 161 transcripts with known coding sequences in this region. The potential candidate genes include those genes that regulate growth and differentiation of bone cells, listed in Table 2 . Sequence analyses of potential candidate genes did not identify polymorphisms in any of the sequenced genes between the mutant and WT samples ( Table 2) .
DISCUSSION
The genetic regulation of the periosteal expansion and cortical thickness is poorly understood. Using a sensitized ENU screening approach to reveal gene function, we have identified a mutant with reduced periosteal perimeter without a significant reduction in body weight. Furthermore, bone length was only slightly reduced (Fig. 1B) in the mutant mice compared with control mice. The mutation affects multiple anatomical sites of the skeletal system, and the mutated gene regulates both trabecular and cortical bone size. The reduction in periosteal circumference was accompanied by a significant reduction in periosteal BFR and not due to increased periosteal bone resorption as reflected by data from dynamic and static histomorphometry (Fig. 2) . Our in vitro studies suggest that the reduction in bone formation at the periosteum could be due to the 14104 locus influencing proliferation potential of periosteal osteoblasts. Further studies are needed to verify the cellular mechanisms that contribute to the observed changes in bone formation and resorption parameters in 14104 mice. In contrast to the decreased bone size, cortical thickness was increased in the mutant mice compared with control mice, which could be a compensatory response to compromised bone strength in these mice. Consistent with this interpretation, Jepsen et al. (2) have demonstrated that slender bones develop thicker cortices to compensate for reduction in bone strength in a recombinant inbred strain of mice. The mechanism that contributes to the increase in cortical thickness in mice with reduced bone size remains to be determined.
Mechanical strain is one of the key physiological regulators of periosteal bone formation. Since previous linkage studies (5) have reported a suggestive locus at marker D11mit333 (71.8 cM) linked to the response to four-point bending, we have compared the bone response to 2 wk axial loading between mutant and control mice. The mutant 14104 mice showed a significant reduction in the bone anabolic response to axial loading compared with WT control mice, which suggests that the mutated gene is also involved in the response to mechanical loading.
Sex hormones differentially regulate periosteal apposition at puberty by both GH-dependent and -independent mechanisms leading to typical sexual dimorphic skeletal changes. Time course studies revealed that the 14104 mutation affects the bone size before the initiation of puberty. We found that bone size differences between mutant and WT mice can be reliably identified as early as 1 wk of age (data not shown). We, therefore, speculate that the 14104 locus influences periosteal apposition during both embryonic and postnatal developmental periods. While GH is located in chromosome 11, it is not in the 14104 locus but is located at 68.89 cM (106.3 Mb based on informatics.jax.org database). Our data indicate that the mutated gene interacts with the GH pathway during postnatal development when the mutant phenotype was modulated by the GH pathway. Thus, it is likely that the effect of 14014 gene is mediated by both GH-independent and GH-dependent mechanisms.
Using a genome-wide approach at a 95% CI, we located the region harboring the mutant locus between chromosomal markers, D11mit181 and D11mit104. We mouse strain for mapping because DBA and B6 strains of mice are highly polymorphic for the markers used in our study and the mutant bone size phenotype was well expressed in the DBA background with a ratio 1:1 of the affected-normal. At marker D11mit338, which showed the highest LOD score, F2 mice with B6 alleles that carry the mutation exhibited a 20% lower periosteal circumference, indicating that this marker is likely to be linked to the mutated gene. Consistent with our data, a number of genetic studies in both mice and human have identified loci in chromosome 11 that regulate skeletal parameters. (22) have identified loci on chromosome 11 that were linked to the material and mechanical properties of cortical bone. However, the effect of these loci was sex dependent, and the genetic positions of all the identified loci were clearly proximal to the 14104 mutant locus. Otsuki et al. (12) identified a QTL on chromosome 11 that had significant linkage to peak bone mass and the cortical thickness index in male mice, but the subcongenic lines of mice developed from SAM2 ϫ SAMP6 narrowed down the support interval between D11mit10 and D11mit224 of chromosome 11, which is sex dependent and overlaps with the proximal region of the mutant 14104 locus. The region for the 14104 locus is syntenic to human chromosome regions 17q21.31 and 17q23.2-24.3, which were linked to femoral head width variations (7) . These data confirm the linkage of the 14104 mutant locus with bone size regulation. Comparison of genes in the support interval of mice and humans will facilitate finding candidate genes to identify the mutation. From the Mouse Genome Informatics database, 161 known transcripts have been identified between D11mit181 and D11mit104 in the 14104 support interval (data not shown). Among these genes, 11 genes have been reported to be involved in the regulation of growth and/or bone metabolism ( Table 2 ). Sequencing analyses of coding regions of these candidate genes did not reveal polymorphisms between the mutant and WT B6 mice, thus suggesting that either the mutation is located in regulatory regions or that genes with currently unknown functions could have an additional but unidentified role in bone metabolism. Future studies are needed to evaluate gene expression differences in the genes identified between D11mit181 and D11mit104 in the 14104 support interval using RNA isolated from periosteal cells derived from WT and mutant mice at a time when the phenotype starts to manifest. Approaches involving functional assays to rescue decreased proliferation potential of periosteal cells derived from mutant mice and sequence analysis of the regulatory regions of the differentially expressed genes could then be used to identify the mutant gene.
In conclusion, using a sensitized ENU screening approach to reveal gene function, we have identified a mutant with reduced bone size but greater cortical BV. The mutation that was mapped to 71.8 -84 cM region of chromosome 11 alters the anabolic response to mechanical loading. The identified locus contains key genes that regulate bone size in humans. Identification of the mutated gene and its pathway would disclose a key component in the genetic regulation of periosteal expansion and cortical BA.
